FDA Digital Health Advisory Committee

https://www.fda.gov/medical-devices/digital-health-center-excellence/fda-digital-health-advisory-committee?utm_medium=email&utm_source=govdelivery The U.S. Food and Drug Administration (FDA) is establishing a Digital Health Advisory Committee to address complex, scientific, and technical issues related to digital health technologies (DHTs). The Committee’s goal is to support safe and effective regulation of digital health technologies while encouraging innovation. The FDA is looking to solicit views from technical and scientific subject matter experts from diverse disciplines and backgrounds for this advisory committee and therefore encourages nominations of appropriately qualified candidates. The Digital Health Advisory Committee will advise the Commissioner of Food and Drugs on issues related to DHTs, providing relevant expertise and perspective to improve Agency understanding of the benefits, risks, and clinical outcomes associated with use of DHTs. If you are interested in serving or nominating a representative to serve as a voting or non-voting member of the FDA's Digital Health Advisory Committee, please submit your nominations no later than December 11, 2023.